Dr. Babatunde Oladiran, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 907 E Reed St, Hayti, MO 63851 Phone: 573-359-3660 Fax: 573-359-3521 |
News Archive
A new Harris Poll finds that large numbers of people either believe damaging misinformation about the health care proposals being discussed in Washington or are not sure what to believe. The polls also shows that almost half of all adults continue to support what they see as President Obama's health care reform proposals, significantly but not substantially more than oppose them.
Single reading events of a signaling molecule at a given time should no longer be considered as the only insightful indicator to predict the usefulness of a new drug candidate.
BioTrends is pleased to announce the fielding of a new syndicated report, LaunchTrends®: ACTEMRA. Roche, Inc. announced that they received FDA approval for Actemra (generic name: tocilizumab) on January 8th. This represents the first IL-6 receptor inhibitor agent approved for Rheumatoid Arthritis (RA); Actemra is approved for adult patients with moderately-to-severely active RA who have had an inadequate response to one or more TNF antagonist therapies. Actemra represents the fourth IV Infusion product in the RA Market and the first infusion product with monthly maintenance dosing.
SP Scientific has announced its Summer 2014 program of LyoLearn webinars.
› Verified 7 days ago